Observational study into specific in vivo human discrimination between benign and malignant tissue using a combination of Diffuse Reflectance and Fluorescence spectroscopy
- Conditions
- Cancermalignancy100198151000623210029107
- Registration Number
- NL-OMON38249
- Lead Sponsor
- Philips Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 113
1. Patients with proven malignant lesion of breast, lung or liver or benign fibroadenoma of the breast
2. In case of breast malignancy; patients are scheduled for total or partial resection of the breast
3. In case of lung malignancy; patients are scheduled for local resection, lobectomy or pneumonectomy during an *open* thoracic procedure
4. In case of liver malignancy; patients are scheduled for local resection or hemi-hepatectomy
5. Patients undergoing RFA for colorectal liver metastases and in whom the RFA-needle trjact will be entirely ablated
6. Written informed consent
7. Patients >= 18 years old
1. Patients with no proof of residual malignant disease after neo-adjuvant therapy by follow-up radiological analysis before operation
2. Patients with suspected sensitivity to light; e.g. patients who have had photodynamic therapy
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method